Unasnemab
Product Specifications
CAS Number
2379805-59-9
Target
RGM
Related Pathways
Neuroscience
Purity
0.983
Bioactivity
Unasnemab (MT-3921), a humanized IgG1 monoclonal antibody, exerts its biological effects by binding to the repulsive guidance molecule A (RGMa), which in turn enhances locomotor function and promotes neuroregeneration. Unasnemab (MT-3921) demonstrates potential utility in the field of spinal cord injury research, where it provides an experimental approach to explore regenerative therapies targeting inhibitory guidance molecules.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6255360-01 0.1 mL
TREM-2 (Triggering Receptor Expressed on Myeloid Cells 2, Trem2a, Trem2b, Trem2c) (MaxLight 550)
Sign In for Pricing
View Details 
MBS6255360-02 5x 0.1 mL
TREM-2 (Triggering Receptor Expressed on Myeloid Cells 2, Trem2a, Trem2b, Trem2c) (MaxLight 550)
Sign In for Pricing
View Details PD09179 250 mg
5,6-Dihydro-5'-O-DMT-thymidine 3'-CE phosphoramidite
Sign In for Pricing
View Details